Scientific Journals
News and Features
AAPS Meetings and Education
  Products and Services
  AAPS Member Services
  AAPS Press Room
  Marketing Opportunities
  Affiliated Organizations
  Join AAPS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AAPS PRESSROOM: News Releases
   Member Directory  Marketplace  News  Annual Meeting  Career Center  Login  

FOR IMMEDIATE RELEASE

Contact:Debbie Werfel

February 23, 2001

703-248-4743

 

werfel@aaps.org

 

Jim Greif

 

703-248-4744

 

greifj@aaps.org

AAPS Announces Workshop on Assuring Quality, Performance of Sustained and Controlled Release Parenterals

ARLINGTON, Va. - The American Association of Pharmaceutical Scientists (AAPS) will present the AAPS Workshop on Assuring Quality and Performance of Sustained and Controlled Release Parenterals on April 19-20, 2001, at the Hyatt Regency Washington on Capitol Hill in Washington, DC. Parenteral describes a method of drug delivery in which the drug enters the body by some means other than the intestine, usually injected in liquid form.

“This groundbreaking event provides a forum to bring together the leaders in industry, government and academia, to discuss the pertinent issues in assuring the quality and performance of sustained and controlled release parenterals,” said workshop co-chair and AAPS President-Elect, Diane Burgess, Ph.D. “This workshop will lay the groundwork for the development of guidelines for regulatory activity in this emerging area. With the biotech and genomic revolutions occurring, these delivery systems are becoming more important.”

This workshop, co-sponsored with FDA and United States Pharmacopeia, will cover dispersed systems (microspheres, liposomes, gels and suspensions) as well as implants of small molecule and protein/peptide therapeutics for human and animal use. Participants in this workshop will engage in discussions and breakout sessions that will identify future directions for regulatory activity and public standards in this rapidly emerging area.

Workshop participants will:

  • Define and review specifications/characterization for delivery device manufacture;
  • Identify and discuss critical process parameters and their control;
  • Discuss accelerated stability and emerging in vitro release testing methods for these products; and,
  • Assess bioavailability, bioequivalence and pharmaceutical equivalence and explore the opportunity for in vitro-in vivo correlation of these products.

Participants will also have an opportunity to meet with suppliers, including Daiichi Jitsuoyo (America) Inc., Hanson Research Corporation, and Southern BioSystems, Inc.

About AAPS
AAPS is a professional, scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Pharmaceutica at www.aapspharmaceutica.com.

* * *



American Association of Pharmaceutical Scientists

2107 Wilson Blvd, Suite 700, Arlington, VA 22201-3046
Main Telephone: 703 243 2800 Main Fax: 703 243 9650
Email: aaps@aaps.org
View disclaimer
Please email your comments or questions regarding this web site to
webmaster@aaps.org